Delisting riskPopularity #3,949
RANI · NASDAQ · Biotechnology

Rani (RANI)

Develops RaniPill capsules for oral delivery of biologics and drugs.

$0.8100
After-hours close+0.03 (+4.13%)
At close$0.7779(−1.46%)
  1. Rani (RANI) Q2 Net Loss Improves 16%

    The Motley Fool